Skip to content.

Spotlight

Featured

Perspectives
Why we invested in Treefera
1 / 8
Read more
Perspectives
Why we invested in Oriole Networks
2 / 8
Read more
Perspectives
Why we invested in Gridcog
3 / 8
Read more
Perspectives
Why we invested in OpenDialog
4 / 8
Read more
Perspectives
Why we invested in kennek?
5 / 8
Read more
Perspectives
Why we invested in tem.?
6 / 8
Read more
Perspectives
Why we invested in Ramp?
7 / 8
Read more
Perspectives
Why we invested in 5Mins?
8 / 8
Read more

Web

The outlook for venture capital & tech in 2024

Christoph Ruedig on the BVCA 40th Anniversary Podcast Series

Read the article >
Web

Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT

Read the article >
Web

Leigh Brody, UCLTF Investor | Career in Discovery Podcast

Leigh Brody, UCLTF investor on TalentSingular’s ‘Careers in discovery’ podcast

Read the article >
Web

Bramble Energy among 23 deeptech startups primed to take off | Business Insider

Bramble Energy | Business Insider

Read the article >
Web

4th Nasdaq IPO for the UCL Technology Fund: Achilles Therapeutics listing 

Nasdaq

Read the article >
Web

Freeline Therapeutics Rings the Nasdaq Opening Bell in Celebration of its IPO

Nasdaq

Read the article >